Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells

Virology

Volumn 318, Issue 1, 2004, Pages 66-78

  Labadie, Karine ^a   Pelletier, Isabelle ^a   Saulnier, Aure ^a   Martin, Javier ^b   Colbère Garapin, Florence ^a  

^a INSTITUT PASTEUR   (France)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Caco 2 cells; CD155; Enterocyte; Enterovirus; Intestine; Persistent infection; Picornavirus; Poliovirus; Vaccine

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL POLARITY; CELL STRAIN CACO 2; CELL SURFACE; CONTROLLED STUDY; EVOLUTION; HUMAN; HUMAN CELL; HYPOGAMMAGLOBULINEMIA; INTESTINE CELL; INTESTINE INFECTION; LYSIS; NONHUMAN; PATIENT; PERSISTENT INFECTION; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VACCINATION; VIRUS ADSORPTION; VIRUS CULTURE; VIRUS EXCRETION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS STRAIN;

ENTEROVIRUS; PICORNAVIRIDAE; POLIOVIRUS;

EID: 1242342160     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.09.005     Document Type: Article

References (44)

1. Ammendolia M.G., Tinari A., Calcabrini A., Superti F. Poliovirus infection induces apoptosis in Caco-2 cells. J. Med. Virol. 59:1999;122-129.
2. Bellmunt A., May G., Zell R., Pring-Akerblom P., Verhagen W., Heim A. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology. 265:1999;178-184.
3. Blondel B., Akacem O., Crainic R., Couillin P., Horodniceanu F. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat-inactivated virions. Virology. 126:1983;707-710.
4. Borzakian S., Couderc T., Barbier Y., Attal G., Pelletier I., Colbère-Garapin F. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology. 186:1992;398-408.
5. Buttinelli G., Donati V., Fiore S., Marturano J., Plebani A., Balestri P., Soresina A.R., Vivarelli R., Delpeyroux F., Martin J., Fiore L. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J. Gen. Virol. 84:2003;1215-1221.
6. Calvez V., Pelletier I., Borzakian S., Colbère-Garapin F. Identification of a region of the poliovirus genome involved in persistent infection of HEp-2 cells. J. Virol. 67:1993;4432-4435.
7. Calvez V., Pelletier I., Couderc T., Pavio-Guedo N., Blondel B., Colbère-Garapin F. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants. Virology. 212:1995;309-322.
8. Colbère-Garapin F., Pelletier I., Ouzilou L. Persistent infections by picornaviruses. Wimmer B.L.S.E. Molecular Biology of Picornaviruses. 2002;437-450 ASM Press, Washington.
9. Costa de Beauregard M.A., Pringault E., Robine S., Louvard D. Suppression of villin expression by antisense RNA impairs brush border assembly in polarized epithelial intestinal cells. EMBO J. 14:1995;409-421.
10. Duncan G., Colbère-Garapin F. Two determinants in the capsid of a persistent type 3 poliovirus exert different effects on mutant virus uncoating. J. Gen. Virology. 80:1999;2601-2605.
11. Duncan G., Pelletier I., Colbère-Garapin F. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions. Virology. 241:1998;14-29.
12. Girard S., Gosselin A.S., Pelletier I., Colbère-Garapin F., Couderc T., Blondel B. Restriction of poliovirus RNA replication in persistently infected nerve cells. J. Gen. Virology. 83:2002;1087-1093.
13. Gosselin A.S., Simonin Y., Guivel-Benhassine F., Rincheval V., Vayssiere J.L., Mignotte B., Colbère-Garapin F., Couderc T., Blondel B. Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells. J. Virol. 77:2003;790-798.
14. Gromeier M., Nomoto A. Determinants of poliovirus pathogenesis. Wimmer B.L.S.E. Molecular Biology of Picornaviruses. 2002;367-380 ASM Press, Washington.
15. He Y., Mueller S., Chipman P.R., Bator C.M., Peng X., Bowman V.D., Mukhopadhyay S., Wimmer E., Kuhn R.J., Rossmann M.G. Complexes of poliovirus serotypes with their common cellular receptor, CD155. J. Virol. 77:2003;4827-4835.
16. Hidalgo I.J., Raut T.J., Borchsardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 96:1989;736-749.
17. Hogle J.M., Racaniello V.R. Poliovirus receptors and cell entry. Wimmer B.L.S.E. Molecular Biology of Picornaviruses. 2002;71-84 ASM Press, Washington.
18. Iwasaki A., Welker R., Mueller S., Linehan M., Nomoto A., Wimmer E. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. J. Infect. Dis. 186:2002;585-592.
19. Kaplan G., Racaniello V.R. Down regulation of poliovirus receptor RNA in HeLa cells resistant to poliovirus infection. J. Virol. 65:1991;1829-1835.
20. Kew O.M., Mulders M.N., Lipskaya G.Y., da Silva E.E., Pallansch M.A. Molecular epidemiology of polioviruses. Semin. Virol. 6:1995;401-414.
21. Kew O.M., Sutter R.W., Nottay B.K., McDonough M.J., Prevots D.R., Quick L., Pallansch M.A. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J. Clin. Microbiol. 36:1998;2893-2899.
22. Koike S., Horie H., Ise I., Okitsu A., Yoshida M., Iizuka N., Takeuchi K., Takegami T., Nomoto A. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9:1990;3217-3224.
23. Lama J., Sanz M.A., Carrasco L. Genetic analysis of poliovirus protein 3A: characterization of a non-cytopathic mutant virus defective in killing Vero cells. J. Gen. Virology. 79:1998;1911-1921.
24. Landsteiner K., Popper E. Ubertragung der Poliomyelitis acuta auf Affen. Z. Immunitätsforsch. 2:1909;377-390.
25. Levaditi C. Virus de la poliomyélite et culture des cellules in vitro. Compt. Rend. Soc. Biol. Paris. 75:1913;202-205.
26. Lopez M., Jordier F., Bardin F., Coulombel L., Chabannon C., Dubreuil P. Identification of a new class of Ig superfamily antigens expressed in hemopoiesis. Kishimoto T.K.H., von dem Borne A.E.G., Goyert S.M., Mason D.Y., Miyasaka M., Moretta M., Okumura K., Shaw S., Springer T.A., Sugamura K., Zola H. Leucocyte Typing VI, White Cell Differentiation Antigens. 1997;1081 Garland, New York.
27. Martin J., Dunn G., Hull R., Patel V., Minor P.D. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J. Virol. 74:2000;3001-3010.
28. Mendelsohn C.L., Wimmer E., Racaniello V.R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin superfamily. Cell. 56:1989;855-865.
29. Minor P. Characteristics of poliovirus strains from long-term excretors with primary immunodeficiencies. Dev. Biol. (Basel). 105:2001;75-80.
30. Minor P.D., Almond J. Poliovirus vaccines: molecular biology and immune response. Wimmer B.L.S.E. Molecular Biology of Picornaviruses. 2002;381-390 ASM Press, Washington.
31. Oprisan G., Combiescu M., Guillot S., Caro V., Combiescu A., Delpeyroux F., Crainic R. Natural genetic recombination between co-circulating heterotypic enteroviruses. J. Gen. Virology. 83:2002;2193-2200.
32. Ouzilou L., Caliot E., Pelletier I., Prevost M.C., Pringault E., Colbère-Garapin F. Poliovirus transcytosis through M-like cells. J. Gen. Virology. 83:2002;2177-2182.
33. Pavio N., Buc-Caron M.H., Colbère-Garapin F. Persistent poliovirus infection of human fetal brain cells. J. Virol. 70:1996;6395-6401.
34. Pelletier I., Couderc T., Borzakian S., Wyckoff E., Crainic R., Ehrenfeld E., Colbère-Garapin F. Characterization of persistent poliovirus mutants selected in human neuroblastoma cells. Virology. 180:1991;729-737.
35. Pelletier I., Duncan G., Colbère-Garapin F. One amino acid change on the capsid surface of poliovirus Sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures. Virology. 241:1998;1-13.
36. Pelletier I., Duncan G., Pavio N., Colbère-Garapin F. Molecular mechanisms of poliovirus persistence: key role of capsid determinants during the establishment phase. Cell. Mol. Life Sci. 54:1998;1385-1402.
37. Pelletier I., Ouzilou L., Arita M., Nomoto A., Colbère-Garapin F. Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating. Virology. 305:2003;55-65.
38. Pinto M., Robine-Leon S., Appay M., Kedinger M., Triadou N., Dussaulx E., Lacroix B., Simon-Assmann P., Haffen K., Fogh J., Zweibaum A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell. 47:1983;323-330.
39. Rossmann M.G. Picornavirus structure overview. Wimmer B.L.S.E. Molecular Biology of Picornaviruses. 2002;27-38 ASM Press, Washington.
40. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680.
41. Tucker S.P., Thornton C.L., Wimmer E., Compans R.W. Bidirectional entry of poliovirus into polarized epithelial cells. J. Virol. 67:1993;29-38.
42. Tucker S.P., Thornton C.L., Wimmer E., Compans R.W. Vectorial release of poliovirus from polarized human intestinal epithelial cells. J. Virol. 67:1993;4274-4282.
43. Van Beers E.H., Al R.H., Rings E.H., Einerhand A.W., Dekker J., Bueller H.A. Lactase and sucrase-isomaltase gene expression during Caco-2 cell differentiation. Biochem. J. 308:1995;769-775.
44. Yoneyama T., Yoshida H., Shimizu H., Yoshii K., Nagata N., Kew O., Miyamura T. Neurovirulence of Sabin 1-derived polioviruses isolated from an immunodeficient patient with prolonged viral excretion. Dev. Biol. (Basel). 105:2001;93-98.